Half of all inflammatory breast cancers are identified at stage 4
Each October, the ritual of breast cancer awareness reminds us how much we think we know — and how much remains in shadow. A survey from Ohio State University has illuminated one such shadow: most American women cannot recognize the signs of inflammatory breast cancer, a rare but ferocious variant that disguises itself as infection rather than malignancy. Because it announces itself not with a lump but with redness, warmth, and swelling, it slips past both patients and physicians alike, often reaching its most advanced stage before anyone thinks to name it. The distance between awareness and knowledge, it turns out, can be measured in lives.
- A survey of over 1,100 women found fewer than half could identify redness, skin thickening, or breast warmth as potential cancer symptoms — even as 78% correctly flagged lumps.
- Inflammatory breast cancer mimics a common breast infection so convincingly that women delay seeking care, and even trained physicians frequently misdiagnose it.
- Half of all inflammatory breast cancer cases are not caught until stage 4, when the cancer has already spread and treatment options have narrowed dramatically.
- Ohio State's new multidisciplinary Inflammatory Breast Cancer Program is building clinical decision protocols and fast-track triage systems to compress the dangerous gap between symptom onset and diagnosis.
- The program is also pushing outreach beyond the hospital — educating primary care doctors and OB-GYNs who may be the first, and only, line of recognition for a disease many have never seen.
October is National Breast Cancer Awareness Month, but a survey from Ohio State University's Comprehensive Cancer Center has exposed a troubling blind spot in what women actually understand about the disease. Researchers questioned more than 1,100 American women about inflammatory breast cancer — a rare form accounting for just 1 to 5 percent of U.S. cases — and found that fewer than half could identify redness, skin thickening, or a sensation of warmth as warning signs. Meanwhile, 78 percent recognized a lump, the symptom that dominates public messaging.
The gap is dangerous because inflammatory breast cancer does not behave like most breast cancers. It presents as a red, swollen, tender breast with an orange-peel skin texture — symptoms that closely resemble a breast infection. Women may assume they have mastitis and seek routine care, only to be misdiagnosed. The disease is so uncommon that many physicians have never encountered it, making it easy to mistake for something far less serious.
Dr. Ko Un Park, surgical oncologist and director of Ohio State's new Inflammatory Breast Cancer Program, stresses the urgency: half of all cases are diagnosed at stage 4, when the cancer has already spread and the window for effective treatment has narrowed. She notes that even clinicians are not trained to view a red breast with suspicion, and that a high index of alertness — followed by swift action — is essential.
To address this, Ohio State has assembled a multidisciplinary team of oncologists, radiologists, surgeons, and nurses who have developed a clinical decision tree to fast-track suspected cases into treatment. The team is also reaching out to general practitioners and gynecologists to sharpen recognition of the disease's subtle presentation. The broader message for women is clear: changes in breast appearance — redness, dimpling, heaviness — deserve medical attention just as much as any lump, and no week of delay should be taken lightly.
October marks National Breast Cancer Awareness Month, but a survey conducted by Ohio State University's Comprehensive Cancer Center has surfaced a troubling gap in what women actually know about one of the disease's most dangerous forms. Researchers asked more than 1,100 American women about the warning signs of inflammatory breast cancer, a rare variant that accounts for only 1 to 5 percent of all breast cancers in the United States. What they found was stark: fewer than half of respondents could identify redness of the breast, thickening or pitting of the skin, or a sensation of warmth or heaviness in one breast as potential cancer symptoms. By contrast, 78 percent of women recognized a lump as a sign of breast cancer—the classic marker that dominates public awareness.
The disconnect matters because inflammatory breast cancer is not a disease that announces itself with a lump. Instead, it mimics the appearance and feel of a breast infection: the skin takes on an orange-peel texture, the breast becomes engorged and tender, the area reddens. A woman might assume she has mastitis or another benign condition and seek treatment from her primary care doctor or gynecologist. Even then, she may be misdiagnosed. The disease is so uncommon that many physicians have never encountered it, and the symptoms are easy to mistake for something far less serious.
Dr. Ko Un Park, a surgical oncologist who directs the new Inflammatory Breast Cancer Program at Ohio State's Stefanie Spielman Comprehensive Breast Center, emphasizes that the stakes are high. Half of all inflammatory breast cancer cases are identified at stage 4—the most advanced stage—by the time a correct diagnosis is made. At that point, the cancer has already spread beyond the breast, and the window for effective treatment has narrowed considerably. Park notes that even within the medical community, the condition is so unfamiliar that doctors are not trained to think of a red breast as a cancer symptom. The disease is sneaky, she says, and challenging to diagnose, which is why clinicians need to develop a high index of suspicion and act quickly when they encounter the telltale signs.
In response to this diagnostic blind spot, Ohio State has assembled a multidisciplinary team dedicated to inflammatory breast cancer. The group includes surgical, medical, and radiation oncologists, breast radiologists, plastic and reconstructive surgeons, physical therapists, and nurses—all working under Park's direction alongside breast radiologist Dr. Amy Kerger. The team has developed a clinical decision tree to help triage patients rapidly and mobilize treatment as quickly as possible. The goal is to move suspected cases to the front of the queue, so that therapy can begin without delay. Beyond the hospital walls, the team is also reaching out to general practitioners and obstetricians and gynecologists to educate them about the disease and its subtle presentation.
The awareness gap revealed by the survey underscores why this outreach matters. Women need to know that unusual changes in the appearance or feel of their breasts warrant a conversation with a doctor—not just lumps, but redness, dimpling, tightening, or a sensation of heaviness. Breast self-examination remains a crucial tool for catching these changes early. And doctors need to be primed to consider inflammatory breast cancer when a patient presents with what looks like a breast infection that does not respond to standard treatment. The new clinic at Ohio State represents one institution's attempt to close that gap, but the larger challenge remains: making both women and their physicians aware of a disease that is rare enough to be overlooked, yet aggressive enough that every week of delay can alter the course of treatment and survival.
Notable Quotes
Inflammatory breast cancer is a sneaky disease and challenging to diagnose. It is critical that clinicians have a high level of familiarity with its subtle signs and be prepared to take immediate action to avoid delayed diagnosis.— Dr. Ko Un Park, surgical oncologist at Ohio State's Comprehensive Cancer Center
The Hearth Conversation Another angle on the story
Why does inflammatory breast cancer get missed so often, even by doctors?
Because it doesn't look like what we've been taught to fear. A lump is obvious. Redness and swelling look like an infection, so a woman goes to her doctor expecting antibiotics, and the doctor prescribes them. If the symptoms don't resolve, that's when someone might think cancer—but by then weeks have passed.
And that delay matters because of the stage at diagnosis?
Exactly. Half of these cases are already stage 4 when they're finally identified. That's not a coincidence. It's the cost of misdiagnosis. The cancer has time to spread while everyone is treating it as something benign.
The survey found that 78 percent of women know a lump is a sign of cancer. Why is that number so high but the others so low?
Because we've spent decades hammering that message into public consciousness. Lumps are what we talk about in awareness campaigns. But inflammatory breast cancer doesn't always make a lump. It makes the skin thick and dimpled, the breast warm and heavy. Those symptoms are invisible in the usual breast cancer conversation.
So the new clinic at Ohio State—what does it actually change?
It creates a pathway. When a patient comes in with a red, swollen breast, the team doesn't assume infection. They have a protocol. They move fast. And they're also training other doctors to think the same way. It's about shifting the default assumption.
Is this a problem that education alone can solve?
It's a start. But you need both: women who know what to watch for, and doctors who are trained to recognize it. Right now, neither group has that knowledge. The clinic is trying to build it on both sides at once.